RHOT1 and Parkinson disease: This is in agreement with recent studies that have described impaired Miro1 degradation under mitochondrial damage in PD patients’ fibroblasts (Hsieh et al, 2016) suggesting that failing to degrade Miro1 after mitochondrial damage may impair the normal progression of mitophagy.